About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Calprotectin I Serum as a Diagnostic Marker

Calprotectin I Serum as a Diagnostic Marker

NCT03474484·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

St. Olavs Hospital

With

Norwegian University of Science and Technology

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

clinically confirmed acute exacerbation of chronic obstructive pulmonary disorder (AECOPD)
COPD diagnosis previously confirmed by spirometry according to the GOLD criteria.

You may not be if

known malignant disease
bronchiectasis
chronic bacterial colonisation of the airways
treatment with an immunosuppressive drug or long-term treatment with antibiotics.
not examined with a chest X-ray at admission

The record

StatusCompleted

PhaseNo phase

Taking part113

StartedApr 2018

UpdatedSep 21, 2018

Conditions

Pulmonary Disease, Chronic Obstructive

Where1

Department of Thoracic and Occupational Medicine
Trondheim, Trøndelag, Norway